Abstract Library

#2770 Evaluation of Early Predictors of Metabolic Syndrome in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET)

Introduction: Metabolic syndrome and obesity (MetS) are supposed to have a role in cancer but data analysing their association with GEP-NET are lacking.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Modica R

Authors: Modica R, Barrea L, Bottiglieri F, de Cicco F, Minotta R,

Keywords: GEP-NET, metabolic syndrome, visceral adiposity index, fatty liver index,

#1675 Abdominal Obesity, Fasting Glucose and Metabolic Syndrome Are Risk Factors for Well Differentiated Digestive Neuroendocrine Tumors

Introduction: Digestive NETs(DNETs)`s incidence has increased last 40 years. Visceral obesity and metabolic syndrome (MetSyn) were recently reported to be associated with several cancers, although not so far with DNET.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Santos A, Santos A, Castro C, Raposo L, Torres I,

Keywords: neuroendocrine tumors, metabolic syndrome, visceral obesity ,

#1414 Non-functioning Adrenal Composite Pheochromocytoma-Ganglioneuroma Simultaneous with Subclinical Cushing's Syndrome Due to Contralateral Adrenal Hyperplasia - An Unusual Presentation

Introduction: “Composite” pheochromocytoma is a rare tumor, consisting of pheochromocytoma and neuroblastic tumors. The definite diagnosis is histological. Subclinical Cushing's syndrome refers to autonomous glucocorticoid production without specific signs and symptoms of Cushing's syndrome.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Kiraly A

Authors: Kiraly A, Muntean V, Domsa I, Ghervan C,

Keywords: adrenal, composite, pheochromocytoma, ganglioneuroma, hypercorticism.,

#918 Hyperinsulinemic Hypoglycemia by an Ovarian Germ Cell Tumor

Introduction: A 76-yr-old woman was admitted to our department for recurrent hot flushes, sweating and dizziness associated with fasting hypoglycemia. Physical examination revealed abdominal obesity and ascites.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Battocchio M, Martini C, De Carlo E, Zatelli M, Trento M,

Keywords: ovary, insulin, SSA, everolimus,

#202 Extreme Obesity Due to Insulinoma Within Multiple Endocrine Neoplasia (MEN) 1 Syndrome

Introduction: Peak incidence of symptoms in women with multiple endocrine neoplasia (MEN) 1 is during the third decade of life. Insulinomas are present in 20% of patients and cause weight gain in 30% of patients.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Kruljac I, Vrkljan M,

Keywords: obesity, multiple endocrine neoplasia, insulinoma,